US Patent 9610346 Recombinant viral vectors
Patent 9610346 was granted and assigned to International AIDS Vaccine Initiative on April, 2017 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 10, 2013
Date of Patent
April 4, 2017
Patent Applicant
Patent Application Number
13792106
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9610346 Recombinant viral vectors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.